5OBF
fAb. AbVance: increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery.
Functional Information from PDB Data
site_id | AC1 |
Number of Residues | 8 |
Details | binding site for residue SO4 L 301 |
Chain | Residue |
L | VAL13 |
L | THR14 |
L | THR17 |
L | ARG32 |
L | HOH443 |
L | HOH450 |
L | HOH461 |
L | HOH462 |
site_id | AC2 |
Number of Residues | 8 |
Details | binding site for residue GOL L 302 |
Chain | Residue |
L | GLN50 |
L | LEU52 |
L | PRO64 |
L | GLU86 |
L | ASP87 |
L | HOH453 |
L | HOH582 |
L | LYS44 |
site_id | AC3 |
Number of Residues | 6 |
Details | binding site for residue GOL L 303 |
Chain | Residue |
L | GLY16 |
L | SER72 |
L | GLU84 |
L | HOH448 |
L | HOH456 |
L | HOH490 |
Functional Information from PROSITE/UniProt
site_id | PS00290 |
Number of Residues | 7 |
Details | IG_MHC Immunoglobulins and major histocompatibility complex proteins signature. YTCEATH |
Chain | Residue | Details |
L | TYR196-HIS202 |